Skip to main content

Advertisement

Table 3 The results of pooled rates of studied items (Supplementary Material: Additional file 1: "Availability of Data and Materials")

From: Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies

Studied items No. of studies Pooled rates(95 % CI) Heterogeneity (I 2,%) Publication bias(P value)
Awareness 43 15.95 (12.87–19.29) 98.9 >0.05
Knowledge 21 17.55 (12.38–24.88) 99.8 >0.05
Acceptability 35 67.25 (58.75–75.21) 99.8 >0.05
Reasons for unwillingness to be HPV vaccinated     
 Assumed low risk 14 33.63 (27.50–40.05) 97.2 >0.05
 Limited use to date 14 36.31 (29.67–43.22) 97.7 >0.05
 Safety 10 50.46 (40.00–60.89) 96.6 >0.05
 Efficacy 14 30.18 (23.96–36.79) 97.3 >0.05
 Vaccine source 11 32.17 (21.14–43.30) 99.2 >0.05
 High price 6 23.72 (13.64–35.59) 98.2 >0.05
Acceptability (for daughters) 12 60.32 (51.25–69.04) 99.2 >0.05
Reasons for unwillingness of parents to vaccinate their daughters     
 Limited use to date 4 32.61 (22.03–44.18) 94.5 >0.05
 Safety and efficacy 7 68.19 (53.13–81.52) 98.6 >0.05
 Vaccine source 7 17.24 (13.87–20.90) 82.8 >0.05
 Too young to vaccinate 7 28.37 (13.69–45.90) 99 >0.05
  1. The pooled rate and 95 % CI are from random effects model